Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Rapid Expansion of Pre-exposure Prophylaxis (PrEP) on HIV Incidence, in a Setting With High HIV Testing and Antiretroviral Treatment Coverage, to Achieve the Virtual Elimination of HIV Transmission by 2020: a NSW HIV Strategy Implementation Project

NCT02870790 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT02870790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02870790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Rapid Expansion of Pre-exposure Prophylaxis (PrEP) on HIV Incidence, in a Setting With High HIV Testing and Antiretroviral Treatment Coverage, to Achieve the Virtual Elimination of HIV Transmission by 2020: a NSW HIV Strategy Implementation Project
Lead sponsor
Kirby Institute
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2016
Completion date
October 31, 2020
Enrollment
9,733 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, sti